Current Position: Full Professor, Academic Discipline MEDS-07-A (MED10), Respiratory Medicine, Department of Translational Medicine, Unife.
Qualifications
1987 - MD Medicine & Surgery, Unife
1990 – Specialized in Respiratory Medicine, University of Parma
TEACHING ACTIVITIES
Professor of Respiratory Medicine in the following Degree Courses:
Medicine
Physiotherapy
Imaging and Radiotherapy Techniques
Master's Degree in Nursing and Midwifery Sciences, Master's Degree in Rehabilitation Sciences of the Health Professions, Master's Degree in Science of Technical Diagnostic Health Professions.
ATTIVITA’ GESTIONALE
- Coordinator of the Graduate School of Respiratory Medicine, Unife;
- Coordinator of the Research centre for Chronic Inflammatory Airways Diseases and Respiratory Smoking related diseases (Centro per lo Studio delle Malattie Infiammatorie Croniche delle Vie Aeree e Patologie Fumo Correlate dell’Apparato Respiratorio (CEMICEF), Unife
- Head of Respiratory Medicine, University Hospital Ferrara.
- Coordinator of several Clinical Trials on the efficacy of innovative treatments/prevention in Obstructive lung diseases.
- Member of the Science Committee del Global Initiative for Chronic Obstructive Lung Disease - GOLD
ATTIVITA’ DI RICERCA
- Pubblications: 593 articles in peer-reviewed Journals, H index = 103, Total Citations: 39750 (as of 1 gennaio 2025, Scopus) e 20 Scientific book chapters.
He has given presentations as invited speaker at international and national meetings
Main research:
- AIFA Call – Independent Research 2016- 2022: Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study. (Coordinator Alberto Papi)
- Obstructive lubg diseases and Sars-CoV2 infections. 2020 (Investigator intiated study, Coordinator Alberto Papi)
- Inflammation in chronic obstructive lung diseases: prognostic biomarkers. 2023. (Investigator intiated study, Coordinator Alberto Papi)
-RSV infection in Hospitalized respiratory Patients– Northen Italy 2023-2024. (Investigator intiated study, Coordinator Alberto Papi)
Main research interests:
The principal field of research is airway inflammation in asthma and COPD and the underlying molecular mechanisms and the pharmacological modulation. Particular interest The role of respiratory viral infections in stable/exacerbated obstructive lung diseases, and the underlying molecular and immunological mechanisms have been studied with particular interest. He has coordinated several studies, particularly in asthma and COPD on innovative strategies, prevention and treatments.
Honours
Honorary Lecturer, University Medicine, University of Southampton (U.K.).
Member of Accademia delle Scienze di Ferrara,
Fellow of The European Respiratory Society (FERS)
Qualifications
1987 - MD Medicine & Surgery, Unife
1990 – Specialized in Respiratory Medicine, University of Parma
TEACHING ACTIVITIES
Professor of Respiratory Medicine in the following Degree Courses:
Medicine
Physiotherapy
Imaging and Radiotherapy Techniques
Master's Degree in Nursing and Midwifery Sciences, Master's Degree in Rehabilitation Sciences of the Health Professions, Master's Degree in Science of Technical Diagnostic Health Professions.
ATTIVITA’ GESTIONALE
- Coordinator of the Graduate School of Respiratory Medicine, Unife;
- Coordinator of the Research centre for Chronic Inflammatory Airways Diseases and Respiratory Smoking related diseases (Centro per lo Studio delle Malattie Infiammatorie Croniche delle Vie Aeree e Patologie Fumo Correlate dell’Apparato Respiratorio (CEMICEF), Unife
- Head of Respiratory Medicine, University Hospital Ferrara.
- Coordinator of several Clinical Trials on the efficacy of innovative treatments/prevention in Obstructive lung diseases.
- Member of the Science Committee del Global Initiative for Chronic Obstructive Lung Disease - GOLD
ATTIVITA’ DI RICERCA
- Pubblications: 593 articles in peer-reviewed Journals, H index = 103, Total Citations: 39750 (as of 1 gennaio 2025, Scopus) e 20 Scientific book chapters.
He has given presentations as invited speaker at international and national meetings
Main research:
- AIFA Call – Independent Research 2016- 2022: Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study. (Coordinator Alberto Papi)
- Obstructive lubg diseases and Sars-CoV2 infections. 2020 (Investigator intiated study, Coordinator Alberto Papi)
- Inflammation in chronic obstructive lung diseases: prognostic biomarkers. 2023. (Investigator intiated study, Coordinator Alberto Papi)
-RSV infection in Hospitalized respiratory Patients– Northen Italy 2023-2024. (Investigator intiated study, Coordinator Alberto Papi)
Main research interests:
The principal field of research is airway inflammation in asthma and COPD and the underlying molecular mechanisms and the pharmacological modulation. Particular interest The role of respiratory viral infections in stable/exacerbated obstructive lung diseases, and the underlying molecular and immunological mechanisms have been studied with particular interest. He has coordinated several studies, particularly in asthma and COPD on innovative strategies, prevention and treatments.
Honours
Honorary Lecturer, University Medicine, University of Southampton (U.K.).
Member of Accademia delle Scienze di Ferrara,
Fellow of The European Respiratory Society (FERS)
